推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 2015年兩會(huì)期間，全國(guó)政協(xié)委員、中國(guó)工程院院士吳以嶺公開(kāi)呼吁，希望建立中藥材收儲(chǔ)制度來(lái)遏制中藥材價(jià)格過(guò)快上漲。據(jù)中國(guó)中藥協(xié)會(huì)發(fā)布的數(shù)據(jù)顯示，2007年至2014年，中藥材價(jià)格指數(shù)由2700點(diǎn)上漲到6600點(diǎn)，常用藥材金銀花、板藍(lán)根等每公斤售價(jià)分別從27元、3元左右最高漲至360元、30元，70%到80%常用中藥材價(jià)格上漲2倍以上。11日廣州有業(yè)內(nèi)人士表示，藥企自建藥材基地對(duì)緩解成本上升壓力作用有限。
近日，記者走訪了廣州清平中藥材交易市場(chǎng)。部分中藥材經(jīng)銷商告訴記者，近年來(lái)中藥材價(jià)格波動(dòng)較大，而鋪?zhàn)?、人力成本等增加，使他們的利?rùn)空間受到擠壓。一藥材鋪老板表示：“中藥材價(jià)格波動(dòng)已經(jīng)不是一天兩天的事兒了，近幾年，三七(120頭)從每公斤40元最高漲至700元左右，太子參從每公斤200多元最高漲至500元左右，中藥材漲價(jià)幅度遠(yuǎn)高于物價(jià)漲幅?！?1日，記者來(lái)到位于濱江路江灣東街的某中藥店，發(fā)現(xiàn)該店已經(jīng)關(guān)門停業(yè)。據(jù)附近知情市民透露，這家中藥店早在2015年2月已結(jié)業(yè)，原因主要在于原材料、鋪?zhàn)獾冉?jīng)營(yíng)成本不斷攀升，利潤(rùn)無(wú)法支持。
